Prostate cancer aggressiveness and age: Impact of p53, BCL-2 and microvessel density
Lisa Calvocoressi, Edward Uchio, John Ko, Krishnan Radhakrishnan, Mihaela Aslan, John Concato
DOI: 10.1136/jim-2018-000804 Published 27 November 2018
Lisa Calvocoressi
1
Clinical Epidemiology Research Center, VA Connecticut Healthcare System, West Haven, Connecticut, USA
2
Yale Center for Analytic Sciences, Yale School of Public Health, New Haven, Connecticut, USA
Edward Uchio
3
Department of Urology, University of California, Irvine, Orange, California, USA
John Ko
1
Clinical Epidemiology Research Center, VA Connecticut Healthcare System, West Haven, Connecticut, USA
Krishnan Radhakrishnan
1
Clinical Epidemiology Research Center, VA Connecticut Healthcare System, West Haven, Connecticut, USA
4
Department of Internal Medicine, College of Medicine, University of Kentucky, Lexington, Kentucky, USA
Mihaela Aslan
1
Clinical Epidemiology Research Center, VA Connecticut Healthcare System, West Haven, Connecticut, USA
5
Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
John Concato
1
Clinical Epidemiology Research Center, VA Connecticut Healthcare System, West Haven, Connecticut, USA
5
Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
Submit a Response to This Article
No eLetters have been published for this article.
Prostate cancer aggressiveness and age: Impact of p53, BCL-2 and microvessel density
Lisa Calvocoressi, Edward Uchio, John Ko, Krishnan Radhakrishnan, Mihaela Aslan, John Concato
Journal of Investigative Medicine Dec 2018, 66 (8) 1142-1146; DOI: 10.1136/jim-2018-000804